The molecular background of urothelial cancer: ready for action?

Eur Urol. 2015 Feb;67(2):202-3. doi: 10.1016/j.eururo.2014.07.017. Epub 2014 Aug 4.

Authors

Michiel S van der Heijden¹, Bas W G van Rhijn²

Affiliations

¹ Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
² Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: [email protected].

PMID: 25103696
DOI: 10.1016/j.eururo.2014.07.017

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers, Tumor / genetics*
Carcinoma / genetics*
Genomics*
Humans
Mutation*
Urinary Bladder Neoplasms / genetics*
Urothelium / pathology*

Substances

Biomarkers, Tumor